FOXP3 and graft versus host disease: At the time of GvHD diagnosis, the gut mucosa of patients who later responded to MSCs had increased mast cell activity, CD8+ T cells, and Forkhead Box P3 (FoxP3)+ cells and lower levels of CD4+, CD56+ and CD68+ cells compared to that of patients who did not respond to MSCs.